Rumor das Carl Zeiss an einer Übernahme von MedX Health (WKN: A0YJHF und Canada: MDX) interessiert ist? Wäre ein cleverer Schachzug.
"and identify potential acquisition, divestiture or merger opportunities"
MEDX HEALTH CORP. ENTERS INTO ADVISORY AGREEMENT WITH BYRON CAPITAL MARKETS MedX Health Corp. (MDX) has entered into an advisory agreement with Byron Capital Markets Ltd. Byron will, over a two-month period commencing on the date of signature of the agreement, facilitate MDX's access to capital markets, and identify potential acquisition, divestiture or merger opportunities. In addition, Byron will provide strategic advice to MDX with the intent to maximize shareholder value, assist with introduction to potential strategic investors and assist MDX in structuring future transactions.
MedX Health Corp. develops, manufactures, and distributes phototherapy devices. Its products comprise MedX phototherapy devices, MedX rehab console systems, MedX rehab handheld lasers, MedX SLD clusters, MedX rehab portable lasers, MedX dental console systems, MedX Oralase (dental) portable lasers, MedXHOME systems, MedX acupuncture console laser systems, and MedX acupuncture portable lasers. The company also provides MoleMate, a non-invasive melanoma screening device early detection of skin cancer. Its products are used by practitioners in clinics, academic facilities, and hospitals as well as by professional athletes and sports teams for the treatment of arthritis, strains, sprains, carpal tunnel syndrome, dental pain, and tissue repair. The company sells its products to medical equipment dealers primarily in Canada, the United States, Europe, and Asia. MedX Health Corp. was incorporated in 1999 and is headquartered in Mississauga, Canada. Detailed MDX:CN Company Description... www.medxhealth.com Founded in 1999
|